- Teladoc Health is garnering a lot of attention lately, but in my opinion, the company has had a strong bull case for years.
- I believe that this once under-the-radar telemedicine company is worthy of investment dollars (even at today's price) because its story keeps getting better.
- I am long Teladoc, and I plan to stay long the stock.
Teladoc Health's (NYSE:TDOC) stock has performed extremely well over the past few years, and 2020 may turn out to be the best year yet. To this point, TDOC shares have outperformed the broader market by over 100 percentage points over the last 52 weeks.
Data by YChartsBut get this, I believe that Teladoc's stock still has room to run. Not only does this small disruptive company have promising near-term business prospects, but it also has a great long-term story to tell. And it helps that Teladoc's story (i.e., bull case) keeps getting better.
The Long-term Story That Is
As I recently described, Teladoc's story is simple: the company is disrupting an industry that needs to be disrupted. The company's suite of services is really starting to catch on, and the recent acquisitions are already bearing fruit (for example, the Best Doctors and Advance Medical acquisitions should continue to positively impact Teladoc's business prospects, as I recently described here).
In addition, I believe that this type of growth (in members, visits, revenue, adjusted EBITDA and operating cash flow) shows that Teladoc is properly positioned in a market that has a tremendous growth profile. Teladoc is far ahead of its competitors in this growing industry, in my opinion, and I do not see anything slowing this company down in the near future.










